51 results
Page 3 of 3
8-K
0py2u5hw45heob i4sr
7 Jan 19
Regulation FD Disclosure
6:31am
8-K
EX-99.1
dkxzjdufhs37wmvy gvm
7 Jan 19
Regulation FD Disclosure
6:31am
8-K
EX-99.2
uy6m0ly8sv2l tr46t
17 Dec 18
Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
8:05am
8-K
EX-99.1
ekdrh42b1jaq3v2gfet
17 Dec 18
Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
8:05am
8-K
EX-99.1
9citrn584 8c1j
8 Nov 18
Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress
7:40am
8-K
EX-99.2
bywmcm
25 Oct 18
Regulation FD Disclosure
10:25am
8-K
EX-99.1
t3g6iif5qt86ih3rv
25 Oct 18
Regulation FD Disclosure
10:25am
8-K
EX-99.1
fnqnuji38mmhcq nl
1 Oct 18
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ksiglrt
9 Aug 18
Ovid Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Recent Clinical Progress
12:00am
8-K
EX-99.1
sp1poh0sm
19 Jul 18
Other Events
6:59am
8-K
EX-99.1
u5n r30pn
8 May 18
Results of Operations and Financial Condition
5:22pm